Page last updated: 2024-08-16

temozolomide and curcumin

temozolomide has been researched along with curcumin in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (5.26)29.6817
2010's14 (73.68)24.3611
2020's4 (21.05)2.80

Authors

AuthorsStudies
Chen, CC; D'Andrea, A; Taniguchi, T1
Escalon, E; Melnick, SJ; Nair, SM; Ramachandran, C1
Dilnawaz, F; Sahoo, SK1
Bandey, I; Chiou, SH; Huang, AP; Tsai, JC; Tu, PH1
Hu, X; Shao, J; Wang, L; Wen, C; Yin, H; You, C; Zhang, W; Zhou, C; Zhou, Y1
Beveridge, RD; Carroll, TA; Collis, SJ; Cox, A; Depondt, ML; Fernando, M; Jellinek, D; Kriplani, DH; Myers, KN; Patil, AA; Roylance, A; Sayal, P1
Battastini, AM; Bishop, AJR; Braganhol, E; Bristot, IJ; Figueiró, F; Forcelini, CM; Gelain, DP; Klafke, K; Moreira, JCF; Morrone, M; Paludo, FJ; Terra, SR; Zanotto-Filho, A1
Fei, X; Shi, L; Wang, Z1
Cai, T; Chen, YD; Liu, Q; Wang, ZF; Wu, H1
Shi, L; Sun, G2
Akasov, R; Burov, S; Chiper, M; Dontenwill, M; Leko, M; Markvicheva, E; Vandamme, T; Zaytseva-Zotova, D1
Chen, CC; Huang, BR; Kao, JY; Lai, SW; Lin, HY; Liu, YS; Lu, DY; Tsai, CH; Way, TD1
Bagherian, A; Banfshe, HR; Davoodvandi, A; Ghaderi, A; Hamblin, MR; Mardani, R; Mirzaei, H; Roudi, B; Shamollaghamsari, S; Taghizadeh, M1
Ali Ahmad, K; Ali Khan, B; Almoshari, Y; Hadi Sultan, M; Iqbal, H; Khan, MK; Razzaq, A; Saeed Alqahtani, S1
Beltzig, L; Christmann, M; Kaina, B1
Hadjighassem, M; Hamblin, MR; Hosseindoost, S; Jafari, A; Mahdian, SMA; Mirzaei, H; Mousavi, SM; Ostadian, A; Rajabi, A; Vousooghi, N1
Cao, P; Li, XM; Liang, GB; Liu, Y; Luo, LH; Xu, YH; Zhu, TZ1
Escalon, E; Lollett, IV; Melnick, SJ; Quirin, KW; Ramachandran, C1

Other Studies

19 other study(ies) available for temozolomide and curcumin

ArticleYear
The Fanconi anemia (FA) pathway confers glioma resistance to DNA alkylating agents.
    Journal of molecular medicine (Berlin, Germany), 2007, Volume: 85, Issue:5

    Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Carmustine; Cell Line, Tumor; Curcumin; Dacarbazine; DNA Modification Methylases; DNA Repair; DNA Repair Enzymes; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Inhibitors; Fanconi Anemia Complementation Group D2 Protein; Fanconi Anemia Complementation Group F Protein; Fanconi Anemia Complementation Group Proteins; Glioma; Guanine; Humans; Protein Processing, Post-Translational; RNA Interference; RNA, Small Interfering; Temozolomide; Time Factors; Transfection; Tumor Suppressor Proteins; Ubiquitins

2007
Potentiation of etoposide and temozolomide cytotoxicity by curcumin and turmeric force™ in brain tumor cell lines.
    Journal of complementary & integrative medicine, 2012, Aug-10, Volume: 9

    Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cerebellar Neoplasms; Curcuma; Curcumin; Dacarbazine; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Glioblastoma; Humans; Inhibitory Concentration 50; Medulloblastoma; Phytotherapy; Plant Extracts; Plants, Medicinal; Rhizome; Temozolomide

2012
Enhanced accumulation of curcumin and temozolomide loaded magnetic nanoparticles executes profound cytotoxic effect in glioblastoma spheroid model.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2013, Volume: 85, Issue:3 Pt A

    Topics: Acridine Orange; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain Neoplasms; Cell Culture Techniques; Cell Death; Cell Line, Tumor; Curcumin; Dacarbazine; Drug Delivery Systems; Drug Synergism; Glioblastoma; Humans; Magnetics; Nanoparticles; Propidium; Staining and Labeling; Temozolomide

2013
Progranulin promotes Temozolomide resistance of glioblastoma by orchestrating DNA repair and tumor stemness.
    Oncogene, 2015, Apr-02, Volume: 34, Issue:14

    Topics: Adult; Aged; Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Cell Movement; Cell Proliferation; Curcumin; Dacarbazine; DNA Damage; DNA Repair; Drug Resistance, Neoplasm; Female; Glioblastoma; Humans; Intercellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred NOD; Mice, SCID; Middle Aged; Neoplastic Stem Cells; Progranulins; Promoter Regions, Genetic; Proto-Oncogene Proteins c-fos; RNA Interference; RNA, Small Interfering; Temozolomide; Transcription Factor AP-1; Transcription Factors; Tumor Cells, Cultured

2015
Curcumin sensitizes glioblastoma to temozolomide by simultaneously generating ROS and disrupting AKT/mTOR signaling.
    Oncology reports, 2014, Volume: 32, Issue:4

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Survival; Curcumin; Dacarbazine; Drug Resistance, Neoplasm; Drug Synergism; Glioblastoma; Humans; Mice; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Signal Transduction; Temozolomide; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2014
FANCD2 re-expression is associated with glioma grade and chemical inhibition of the Fanconi Anaemia pathway sensitises gliomas to chemotherapeutic agents.
    Oncotarget, 2014, Aug-15, Volume: 5, Issue:15

    Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Carmustine; Cell Line, Tumor; Curcumin; Dacarbazine; Fanconi Anemia; Fanconi Anemia Complementation Group D2 Protein; Glioma; Humans; Neoplasm Grading; Temozolomide

2014
Autophagy inhibition improves the efficacy of curcumin/temozolomide combination therapy in glioblastomas.
    Cancer letters, 2015, Mar-28, Volume: 358, Issue:2

    Topics: Animals; Apoptosis; Autophagy; Brain Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Curcumin; Dacarbazine; Dose-Response Relationship, Drug; Drug Synergism; Glioblastoma; Humans; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Rats; Temozolomide

2015
Demethoxycurcumin was prior to temozolomide on inhibiting proliferation and induced apoptosis of glioblastoma stem cells.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2015, Volume: 36, Issue:9

    Topics: Apoptosis; Caspase 3; Cell Proliferation; Curcumin; Dacarbazine; Diarylheptanoids; Glioblastoma; Humans; Neoplastic Stem Cells; Primary Cell Culture; Reactive Oxygen Species; Signal Transduction; Temozolomide

2015
Induction of microRNA-146a is involved in curcumin-mediated enhancement of temozolomide cytotoxicity against human glioblastoma.
    Molecular medicine reports, 2015, Volume: 12, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Curcumin; Dacarbazine; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; MicroRNAs; NF-kappa B; Signal Transduction; Temozolomide

2015
Low-Dose DMC Significantly Enhances the Effect of TMZ on Glioma Cells by Targeting Multiple Signaling Pathways Both In Vivo and In Vitro.
    Neuromolecular medicine, 2015, Volume: 17, Issue:4

    Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Division; Cell Line, Tumor; Curcumin; Dacarbazine; Diarylheptanoids; Drug Synergism; G1 Phase; Glioblastoma; Humans; Janus Kinases; Mice; Mice, Nude; Neoplasm Proteins; Reactive Oxygen Species; Signal Transduction; STAT3 Transcription Factor; Temozolomide; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays

2015
Formation of multicellular tumor spheroids induced by cyclic RGD-peptides and use for anticancer drug testing in vitro.
    International journal of pharmaceutics, 2016, Jun-15, Volume: 506, Issue:1-2

    Topics: Antineoplastic Agents; Cell Culture Techniques; Cell Line, Tumor; Chemistry, Pharmaceutical; Curcumin; Dacarbazine; Doxorubicin; Drug Screening Assays, Antitumor; HCT116 Cells; Hep G2 Cells; Humans; MCF-7 Cells; Oligopeptides; Peptides, Cyclic; Spheroids, Cellular; Temozolomide

2016
DMC is not better than TMZ on intracranial anti-glioma effects.
    Journal of cellular biochemistry, 2018, Volume: 119, Issue:7

    Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Brain Neoplasms; Cell Proliferation; Curcumin; Diarylheptanoids; Glioma; Humans; Male; Mice; Mice, Nude; Temozolomide; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2018
Curcumin Promotes Connexin 43 Degradation and Temozolomide-Induced Apoptosis in Glioblastoma Cells.
    The American journal of Chinese medicine, 2019, Volume: 47, Issue:3

    Topics: Antineoplastic Agents, Alkylating; Apoptosis; Connexin 43; Curcumin; Glioblastoma; Humans; Proteolysis; Stimulation, Chemical; Temozolomide; Tumor Cells, Cultured

2019
Combination Therapy with Nanomicellar-Curcumin and Temozolomide for In Vitro Therapy of Glioblastoma Multiforme via Wnt Signaling Pathways.
    Journal of molecular neuroscience : MN, 2020, Volume: 70, Issue:10

    Topics: Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Curcumin; Drug Synergism; Glioblastoma; Humans; Temozolomide; Wnt Signaling Pathway

2020
Development of nanocubosomes co-loaded with dual anticancer agents curcumin and temozolomide for effective Colon cancer therapy.
    Drug delivery, 2022, Volume: 29, Issue:1

    Topics: Antineoplastic Agents; Cell Line, Tumor; Colonic Neoplasms; Curcumin; Drug Carriers; Drug Liberation; Humans; Nanoparticles; Particle Size; Serum Albumin, Bovine; Temozolomide

2022
Abrogation of Cellular Senescence Induced by Temozolomide in Glioblastoma Cells: Search for Senolytics.
    Cells, 2022, 08-19, Volume: 11, Issue:16

    Topics: Artesunate; Cellular Senescence; Curcumin; Glioblastoma; Humans; Lomustine; Neoplasm Recurrence, Local; NF-kappa B; Poly(ADP-ribose) Polymerase Inhibitors; Senotherapeutics; Temozolomide

2022
Exosomes released from U87 glioma cells treated with curcumin and/or temozolomide produce apoptosis in naive U87 cells.
    Pathology, research and practice, 2023, Volume: 245

    Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Cell Line, Tumor; Curcumin; Drug Resistance, Neoplasm; Exosomes; Glioblastoma; Glioma; HSP27 Heat-Shock Proteins; Temozolomide; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53

2023
β-Elemene inhibits proliferation through crosstalk between glia maturation factor β and extracellular signal‑regulated kinase 1/2 and impairs drug resistance to temozolomide in glioblastoma cells.
    Molecular medicine reports, 2014, Volume: 10, Issue:2

    Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Cell Survival; Curcuma; Dacarbazine; Down-Regulation; Drug Resistance, Neoplasm; Flavonoids; Glia Maturation Factor; Glioblastoma; Humans; Inhibitor of Apoptosis Proteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; RNA Interference; RNA, Small Interfering; Sesquiterpenes; Survivin; Temozolomide

2014
Anticancer potential and mechanism of action of mango ginger (Curcuma amada Roxb.) supercritical CO₂ extract in human glioblastoma cells.
    Journal of evidence-based complementary & alternative medicine, 2015, Volume: 20, Issue:2

    Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Carbon Dioxide; Cell Line, Tumor; Cell Survival; Curcuma; Dacarbazine; Etoposide; Glioblastoma; Humans; Mice; Plant Extracts; Reverse Transcriptase Polymerase Chain Reaction; Temozolomide

2015